Updated recommendations to minimise the risk of the rare brain infection PML with Tysabri

View source ↗

Summary

The EMA published updated recommendations to minimize the risk of progressive multifocal leukoencephalopathy (PML) associated with Tysabri (natalizumab), includ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Multiple Sclerosis
• Progressive Multifocal Leukoencephalopathy

Drugs mentioned

• Tysabri (Natalizumab)